Baxter International Inc. (BAX) Stock

Healthcare · Medical Instruments & Supplies · Member of S&P 500

Baxter International Inc. (BAX) closed at USD 24.80 on 2026-10-14, a change of +8.7 % over the past year, with a market capitalization of USD 13.32B.

Baxter International Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Baxter International Inc. key figures

Previous close

USD 24.80 (2026-10-14)

1-year change

+8.7 %

Market cap

USD 13.32B

Enterprise value

USD 20.81B

P/E ratio (trailing)

-13.70

P/E ratio (forward)

12.63

EPS (trailing)

-1.88

EPS (forward)

2.04

PEG ratio

36.68

Price to book

2.15

Revenue growth

5.3 %

Earnings growth

36.8 %

Dividend per share (trailing)

0.20

Short ratio

3.67

Employees

37,500

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Baxter International Inc. and compare it with other stocks.